We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+6.01%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+529.74%
AUM
$122B
AUM Growth
+$25.4B
Cap. Flow
+$19.9B
Cap. Flow %
16.27%
Top 10 Hldgs %
24.28%
Holding
7,416
New
435
Increased
3,853
Reduced
2,246
Closed
356

Sector Composition

Rank Sector Weight
1 Technology 7.07%
2 Financials 5.97%
3 Healthcare 5.8%
4 Consumer Discretionary 5.2%
5 Communication Services 4.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRH
6401
DELISTED
BLUE CAPITAL REINSURANCE HOLDINGS LTD.
BCRH
$11K ﹤0.01%
964
+828
+609% +$11.1K
FRED
6402
PUT
DELISTED
Fred's Inc
FRED
$11K ﹤0.01%
2,800
-7,700
-73% -$37.4K
SONC
6403
CALL
DELISTED
Sonic Corp
SONC
$11K ﹤0.01%
400
-5,200
-93% -$134K
VVUS
6404
CALL
DELISTED
Vivus Inc
VVUS
$11K ﹤0.01%
2,090
AST
6405
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$11K ﹤0.01%
4,746
+4,069
+601% +$10.3K
OSG
6406
PUT
Octave Specialty Group
OSG
$243M
$10K ﹤0.01%
600
-400
-40% -$6.15K
ATNM icon
6407
Actinium Pharmaceuticals
ATNM
$26.3M
$10K ﹤0.01%
500
BBGI icon
6408
Beasley Broadcasting Group
BBGI
$37.8M
$10K ﹤0.01%
39
+33
+550% +$7.49K
CORN icon
6409
CALL
Teucrium Corn Fund
CORN
$176M
$10K ﹤0.01%
600
-30,500
-98% -$520K
DOV icon
6410
CALL
Dover
DOV
$27.6B
$10K ﹤0.01%
124
-19,932
-99% -$1.54M
DRV icon
6411
CALL
Direxion Daily Real Estate Bear 3X ETF
DRV
$26.5M
$10K ﹤0.01%
20
+6
+43% +$3.19K
EWH icon
6412
CALL
iShares MSCI Hong Kong ETF
EWH
$1.24B
$10K ﹤0.01%
400
-7,600
-95% -$192K
JHG
6413
DELISTED
Janus Henderson
JHG
$10K ﹤0.01%
256
-115,110
-100% -$4.15M
PXJ icon
6414
Invesco Oil & Gas Services ETF
PXJ
$65.9M
$10K ﹤0.01%
200
RACE icon
6415
PUT
Ferrari
RACE
$69.2B
$10K ﹤0.01%
100
ST icon
6416
CALL
Sensata Technologies
ST
$6.74B
$10K ﹤0.01%
+200
New +$9.85K
TKR icon
6417
PUT
Timken Company
TKR
$9.56B
$10K ﹤0.01%
200
-5,300
-96% -$257K
TPC
6418
CALL
Tutor Perini Cor
TPC
$4.41B
$10K ﹤0.01%
+400
New +$10.6K
GHL
6419
PUT
DELISTED
Greenhill & Co., Inc.
GHL
$10K ﹤0.01%
500
-4,800
-91% -$89.3K
ZYNE
6420
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$10K ﹤0.01%
+800
New +$9.17K
MANT
6421
PUT
DELISTED
Mantech International Corp
MANT
$10K ﹤0.01%
+200
New +$9.71K
OMN
6422
CALL
DELISTED
OMNOVA Solutions Inc.
OMN
$10K ﹤0.01%
+1,000
New +$10.7K
INSY
6423
PUT
DELISTED
Insys Therapeutics, Inc.
INSY
$10K ﹤0.01%
+1,000
New +$6.54K
TNTR
6424
DELISTED
Tintri, Inc. Common Stock
TNTR
$10K ﹤0.01%
1,877
+1,653
+738% +$7.37K
FMSA
6425
PUT
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
$10K ﹤0.01%
2,000
-1,300
-39% -$6.12K

Similar funds

Barclays's Q4 2017 Portfolio in Review

As of Q4 2017, Barclays held 7,416 positions worth $122B, up 26% from $97.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Barclays deployed $19.9B of net new capital in Q4 2017, opening 435 new positions and adding to 3,853 existing holdings. Its largest new stake was iShares US Home Construction ETF: 198,606 shares worth $8.68M.

By sector, the portfolio is most concentrated in Technology at 7.1% of assets, up from 6.2% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Altaba Inc, an estimated $267M trimmed.

  • Barclays's largest Q4 2017 buy was iShares US Home Construction ETF: 198,606 shares worth $8.68M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $1.24B increase.
  • Barclays's biggest Q4 2017 reduction was Altaba Inc, cutting an estimated $267M.
  • Barclays fully exited CR Bard Inc. in Q4 2017, selling an estimated $134M.
  • Barclays's ten largest holdings make up 24% of its $122B portfolio in Q4 2017.
  • Barclays opened 435 new positions and closed 356 in Q4 2017.
  • Barclays's portfolio value rose 26% quarter-over-quarter to $122B.

Based on Barclays's 13F filing for Q4 2017, filed 14 Feb 2018.